Effectiveness of Opicapone in Parkinson's according to baseline use of dopamine agonists: the real-world OPTIPARK study

被引：0
|
作者：
Jost, W. [1 ]
Reichmann, H. [2 ]
Lees, A. [3 ]
Marinho, D. [4 ]
Magalhaes, D. [4 ]
Rocha, J. F. [4 ]
Soares-da-Silva, P. [4 ]
机构：
[1] Parkinson Klin Ortenau, Wolfach, Germany
[2] Univ Dresden, Dept Neurol, Dresden, Germany
[3] Natl Hosp Neurol & Neurosurg, Dept Clin & Movement Neurosci, London, England
[4] BIAL Portela & Ca SA, Coronado, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
MOTOR FLUCTUATIONS; LEVODOPA; DISEASE; ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-747
引用
收藏
页码：905 / 905
页数：1
相关论文
共 50 条
  • [21] Opicapone in Parkinson's patients with motor fluctuations and complications of therapy at baseline: the OPTIPARK study
    Reichmann, H.
    Lees, A.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 353 - 354
  • [22] Parkinson's Disease Patient Characteristics in a US Real-World Study of Opicapone
    LeWitt, Peter A.
    Klepitskaya, Olga
    Serbin, Michael
    Jen, Eric
    Rattana, Stacy K.
    Trotter, Jeff
    Liang, Grace S.
    ANNALS OF NEUROLOGY, 2022, 92 : S119 - S120
  • [23] Effectiveness and Safety of Opicapone in Clinical Practice in Parkinson's Disease Patients with Motor Fluctuations: the OPTIPARK Study
    Reichmann, Heinz
    Lees, Andrew
    Rocha, Jose-Francisco
    Magalhaes, Diogo
    Soares-da-Silva, Patricio
    NEUROLOGY, 2020, 94 (15)
  • [24] Opicapone in Parkinson's Disease: Real-World Data from a Portuguese Center
    Meira-Carvalho, Filipa
    Da Silva, Jorge Diogo
    Rodrigues, Margarida
    EUROPEAN NEUROLOGY, 2021, 84 (02) : 129 - 131
  • [25] OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson's disease and Motor Fluctuations
    LeWitt, P.
    Klepitskaya, O.
    Bahroo, L.
    Liang, G.
    Rattana, S.
    Trotter, J.
    Serbin, M.
    MOVEMENT DISORDERS, 2021, 36 : S182 - S183
  • [26] Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations and complications of therapy at baseline: Findings from the OPTIPARK study
    Reichmann, Heinz
    Lees, Andrew
    Fonseca, Miguel
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 283 - 283
  • [27] OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson's Disease and Motor Fluctuations
    LeWitt, Peter
    Klepitskaya, Olga
    Bahroo, Laxman B.
    Liang, Grace S.
    Rattana, Stacy
    Trotter, Jeffrey
    Serbin, Michael
    ANNALS OF NEUROLOGY, 2021, 90 : S148 - S148
  • [28] Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
    Heinz Reichmann
    Andrew Lees
    José-Francisco Rocha
    Diogo Magalhães
    Patrício Soares-da-Silva
    Translational Neurodegeneration, 9
  • [29] Opicapone in clinical practice in Parkinson's disease patients with motor fluctuations and complications of therapy at baseline: findings from the OPTIPARK study
    Reichmann, H.
    Lees, A.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S230 - S232
  • [30] Opicapone in Parkinson's German Patients with Motor Fluctuations: findings from the OPTIPARK Study
    Reichmann, H.
    Lees, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 354 - 355
12345